Evidence map›Paper›PMID 33159459›Full record

ArticleParasitology research2021

Trichomonas vaginalis serostatus and prostate cancer risk in Egypt: a case-control study.

Nora E Saleh, Samar M Alhusseiny, Wafaa M El-Zayady, Engy M Aboelnaga, Wafaa N El-Beshbishi, Yasser M Saleh, Hala S Abou-ElWafa, Samar N El-Beshbishi

Abstract read
PubMed Publisher
In one paragraph

Article in Parasitology research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. No Association ofCancers · 2023
    Article
  5. Article
  6. Multiple pathogens and prostate cancer.Infectious agents and cancer · 2022
    Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Nora E SalehDepartment of Medical Parasitology, Faculty of Medicine, Mansoura University, 2 El-Gomhouria Street, Mansoura, 35516, Egypt.
Samar M AlhusseinyDepartment of Medical Parasitology, Faculty of Medicine, Mansoura University, 2 El-Gomhouria Street, Mansoura, 35516, Egypt.
Wafaa M El-ZayadyDepartment of Medical Parasitology, Faculty of Medicine, Mansoura University, 2 El-Gomhouria Street, Mansoura, 35516, Egypt.
Engy M AboelnagaDepartment of Clinical Oncology and Nuclear Medicine, Mansoura University Hospital, Faculty of Medicine, Mansoura University, Mansoura, 35516, Egypt.
Wafaa N El-BeshbishiDepartment of Clinical Oncology and Nuclear Medicine, Mansoura University Hospital, Faculty of Medicine, Mansoura University, Mansoura, 35516, Egypt.
Yasser M SalehDepartment of Clinical Oncology and Nuclear Medicine, Mansoura University Hospital, Faculty of Medicine, Mansoura University, Mansoura, 35516, Egypt.
Hala S Abou-ElWafaDepartment of Public Health and Community Medicine, Faculty of Medicine, Mansoura University, Mansoura, 35516, Egypt.
Samar N El-BeshbishiDepartment of Medical Parasitology, Faculty of Medicine, Mansoura University, 2 El-Gomhouria Street, Mansoura, 35516, Egypt. selbeshbishi@mans.edu.eg.ORCID http://orcid.org/0000-0002-6564-6852
Mansoura University · EGMansoura University Hospital · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Trichomonas vaginalis is one of the most common non-viral sexually transmitted infections (STIs) that has been associated with prostate cancer in some countries. This study aims to investigate if T. vaginalis infection can be a risk factor for prostate cancer in Egypt and its possible relationship with cancer prognostic factors and overall survival. Serum samples were collected from a total of 445 age-matched males; 126 with prostate cancer, 108 with bladder cancer, 91 with different types of cancers, and 120 healthy controls, and then analyzed by ELISA for detection of anti-Trichomonas IgG and prostate-specific antigen (PSA). The results revealed that only 8.3% of controls were seropositive for trichomoniasis, compared with 19% of prostate cancer patients (P = 0.015). There were positive associations between the levels of PSA and tumor stage with T. vaginalis IgG optical density scores among the seropositive cases (P < 0.001 and < 0.05, respectively). However, no significant correlations were detected between seropositivity of T. vaginalis and other prognostic factors or overall survival in those patients. In conclusion, chronic T. vaginalis infection may be associated with prostate cancer, but it does not seem that this STI aggravates the cancer status.

Indexed as

AdultAgedAntibodies, ProtozoanCase-Control StudiesEgyptEnzyme-Linked Immunosorbent AssayFemaleHumansImmunoglobulin GMaleMiddle AgedPrognosisProstate-Specific AntigenProstatic NeoplasmsRisk FactorsTrichomonas InfectionsAntibodies, ProtozoanImmunoglobulin GProstate-Specific AntigenAnti-Trichomonas IgGELISAProstate cancerProstate specific antigenTrichomonas vaginalis

Identifiers

PMID33159459
OpenAlexW3097811394

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.